Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
||||||
GSE248034 |
Contribution of UPF1 and RCOR1 to androgen response of prostate cancer cells.
|
|
18 | Eduardo Cortes | May 15, 2025 | |||
GSE262659 |
Pediatric Sickle Cell Disease Humoral Immunophenotype Alterations
|
|
18 | Patrycja M Dubielecka | May 15, 2025 | |||
GSE265844 |
mRNA-seq of human adipose tissue-derived mesenchymal stem/stromal cells (MSCs)
|
|
8 | Daisuke Hisamatsu | May 15, 2025 | |||
GSE272392 |
Transcriptional response to the SARS-CoV-2 Delta variant in patients with severe COVID-19
|
|
12 | Ivan Nikolaevitch Vlasov | May 15, 2025 | |||
GSE273736 |
Impact of BCL2 Overexpression in castration resistance prostate cancer progression I
|
|
8 | Nabila Zaman | May 15, 2025 | |||
GSE273737 |
Impact of androgen stimulation on BCL2 Overexpressed LNCaP cells
|
|
8 | Nabila Zaman | May 15, 2025 | |||
GSE273738 |
Impact of BCL2 inhibitor Venetoclax on LNCaP cells
|
|
8 | Nabila Zaman | May 15, 2025 | |||
GSE283100 |
Epigenetic modulation of γ-globin expression as a new therapeutic approach for sickle cell disease
|
|
14 | Oriana Romano | May 15, 2025 | |||
GSE291865 |
Multi-omics analyses construct an inflammatory response based prognostic gene signature for cervical cancer and suggest tumor infiltrating monocytes subgroups as key players
|
|
23 | Yidong Zhang | May 15, 2025 | |||
GSE293694 |
Transcriptomic Profiling of TNFα-Stimulated Human Umbilical Vein Endothelial Cells (HUVECs) With and Without Isoginkgetin (ISOGK) Pretreatment.
|
|
6 | ZHIDAN ZHANG | May 15, 2025 | |||
GSE295223 |
Patient-derived kidney organoids recapitulate ADPKD and enable the identification of RHO signaling inhibitors as candidate therapeutics
|
|
3 | liqiang guo | May 15, 2025 | |||
GSE296369 |
Patient-derived kidney organoids recapitulate ADPKD and enable the identification of RHO signaling inhibitors as candidate therapeutics [RNA-Seq]
|
|
6 | liqiang guo | May 15, 2025 | |||
GSE296549 |
Latent EBV impairs immune cell signaling and enhances the efficacy of anti-CD3 mAb in Type 1 Diabetes.
|
|
18 | Stephanie Osmond | May 15, 2025 | |||
GSE296776 |
Type 2 cytokines pleiotropically modulate sensory nerve architecture and neuroimmune interactions to mediate itch [Human DRG]
|
|
9 | Yingnan Han | May 15, 2025 | |||
GSE296833 |
Preclinical and first-in-human of Purinostat Mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed or refractory multiple myeloma and lymphoma [PDX]
|
|
6 | Qiang Qiu | May 15, 2025 | |||
GSE296835 |
Preclinical and first-in-human of Purinostat Mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed or refractory multiple myeloma and lymphoma
|
|
9 | Qiang Qiu | May 15, 2025 | |||
GSE297112 |
Coordinated Histone Methylation Loss and MYC Activation Promote Translational Capacity Under Amino Acid Restriction
|
|
6 | Siavash K Kurdistani | May 15, 2025 | |||
GSE297222 |
TimeLapse-seq after translation inhibition in YTHDF-depleted Hela cells
|
|
12 | Samie Jaffrey | May 15, 2025 | |||
GSE190338 |
Single cell RNA-sequencing analysis of acute graft-versus-host disease (GVHD) skin lesions
|
|
2 | Jennifer Yunyan Zhang | May 14, 2025 | |||
GSE191335 |
Single cell RNA-sequencing analysis of chronic graft-versus-host disease (GVHD) skin lesions
|
|
4 | Jennifer Yunyan Zhang | May 14, 2025 |